Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Merck Inventory 2010-2025 | MKKGY

Merck inventory from 2010 to 2025. Inventory can be defined as the total value of inventories in all stages of completion.
  • Merck inventory for the quarter ending March 31, 2025 was $4.754B, a 7.14% decline year-over-year.
  • Merck inventory for 2024 was $4.852B, a 3.32% decline from 2023.
  • Merck inventory for 2023 was $5.019B, a 2.81% increase from 2022.
  • Merck inventory for 2022 was $4.881B, a 5.79% increase from 2021.
  
Merck Annual Inventory
(Millions of US $)
2024 $4,852
2023 $5,019
2022 $4,881
2021 $4,614
2020 $3,763
2019 $3,743
2018 $3,264
2017 $2,975
2016 $2,885
2015 $2,907
2014 $2,206
2013 $1,958
2012 $1,973
2011 $2,356
2010 $0
2009 $0
Merck Quarterly Inventory
(Millions of US $)
2025-03-31 $4,754
2024-12-31 $4,852
2024-09-30 $4,844
2024-06-30 $5,077
2024-03-31 $5,120
2023-12-31 $5,019
2023-09-30 $5,410
2023-06-30 $5,448
2023-03-31 $5,249
2022-12-31 $4,881
2022-09-30 $4,895
2022-06-30 $4,761
2022-03-31 $4,649
2021-12-31 $4,614
2021-09-30 $4,434
2021-06-30 $4,294
2021-03-31 $4,174
2020-12-31 $3,763
2020-09-30 $4,007
2020-06-30 $3,895
2020-03-31 $3,798
2019-12-31 $3,743
2019-09-30 $3,486
2019-06-30 $3,409
2019-03-31 $3,336
2018-12-31 $3,264
2018-09-30 $3,272
2018-06-30 $3,230
2018-03-31 $3,324
2017-12-31 $2,975
2017-09-30 $3,169
2017-06-30 $2,969
2017-03-31 $2,883
2016-12-31 $2,885
2016-09-30 $2,925
2016-06-30 $2,982
2016-03-31 $2,872
2015-12-31 $2,907
2015-09-30 $1,998
2015-06-30 $1,984
2015-03-31 $2,048
2014-12-31 $2,206
2014-09-30 $2,197
2014-06-30 $2,221
2014-03-31 $2,072
2013-12-31 $1,958
2013-09-30 $2,074
2013-06-30 $2,002
2013-03-31 $2,060
2012-12-31 $1,973
2012-09-30 $2,014
2012-06-30 $2,143
2012-03-31
2011-12-31 $2,356
2011-09-30
2011-06-30 $2,367
2011-03-31
2010-12-31
2010-09-30 $2,288
2010-06-30
2010-03-31
2009-12-31
2009-09-30
2009-06-30
2009-03-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $16.905B $22.569B
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $85.929B 32.24
Zoetis (ZTS) United States $70.240B 26.21
Takeda Pharmaceutical (TAK) Japan $47.983B 9.54
Daiichi Sankyo, - (DSNKY) Japan $44.148B 22.63
BeOne Medicines - (ONC) Cayman Islands $29.241B 0.00
Sandoz Group AG (SDZNY) Switzerland $23.170B 0.00
Summit Therapeutics (SMMT) United States $15.537B 0.00
Shionogi (SGIOY) Japan $14.870B 14.90
United Therapeutics (UTHR) United States $13.078B 11.57
Neurocrine Biosciences (NBIX) United States $12.685B 43.45
Orion OYJ (ORINY) Finland $10.469B 28.31
IPSEN (IPSEY) France $9.739B 0.00
Corcept Therapeutics (CORT) United States $8.141B 66.18
Stevanato Group S.p.A (STVN) Italy $7.447B 45.54
Madrigal Pharmaceuticals (MDGL) United States $6.327B 0.00
Ionis Pharmaceuticals (IONS) United States $6.309B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Grifols, S.A (GRFS) Spain $5.872B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.031B 15.30
Soleno Therapeutics (SLNO) United States $4.242B 0.00
Crinetics Pharmaceuticals (CRNX) United States $2.897B 0.00
Hypermarcas (HYPMY) Brazil $2.850B 18.75
Catalyst Pharmaceuticals (CPRX) United States $2.692B 9.43
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.548B 13.78
BioCryst Pharmaceuticals (BCRX) United States $2.078B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.066B 0.00
Indivior (INDV) United States $1.919B 8.14
Centessa Pharmaceuticals (CNTA) United Kingdom $1.896B 0.00
ARS Pharmaceuticals (SPRY) United States $1.648B 0.00
Endo (NDOI) United States $1.595B 0.00
Evotec AG (EVO) Germany $1.449B 0.00
Ocular Therapeutix (OCUL) United States $1.448B 0.00
Guardian Pharmacy Services (GRDN) United States $1.304B 0.00
Dyne Therapeutics (DYN) United States $1.208B 0.00
Harrow (HROW) United States $1.163B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.088B 21.76
Enliven Therapeutics (ELVN) United States $1.038B 0.00
Verve Therapeutics (VERV) United States $0.996B 0.00
Collegium Pharmaceutical (COLL) United States $0.967B 5.22
Akebia Therapeutics (AKBA) United States $0.964B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.929B 0.00
Ardelyx (ARDX) United States $0.880B 0.00
Elite Pharmaceuticals (ELTP) United States $0.828B 0.00
Cronos Group (CRON) Canada $0.729B 0.00
Xeris Biopharma Holdings (XERS) United States $0.729B 0.00
Liminatus Pharma (LIMN) United States $0.694B 0.00
Xencor (XNCR) United States $0.589B 0.00
Altimmune (ALT) United States $0.583B 0.00
KalVista Pharmaceuticals (KALV) United States $0.582B 0.00
USANA Health Sciences (USNA) United States $0.572B 12.43
Amylyx Pharmaceuticals (AMLX) United States $0.571B 0.00
Relay Therapeutics (RLAY) United States $0.567B 0.00
Regulus Therapeutics (RGLS) United States $0.565B 0.00
Bioventus (BVS) United States $0.555B 14.08
Theravance Biopharma (TBPH) United States $0.534B 0.00
Zevra Therapeutics (ZVRA) United States $0.500B 0.00
AleAnna (ANNA) United States $0.484B 0.00
Siga Technologies (SIGA) United States $0.457B 9.55
Oruka Therapeutics (ORKA) United States $0.440B 0.00
Organogenesis (ORGO) United States $0.439B 0.00
Tourmaline Bio (TRML) United States $0.435B 0.00
Savara (SVRA) United States $0.394B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.334B 9.03
Heron Therapeutics (HRTX) United States $0.328B 0.00
Aquestive Therapeutics (AQST) United States $0.319B 0.00
Nektar Therapeutics (NKTR) United States $0.304B 0.00
Nature's Sunshine Products (NATR) United States $0.279B 25.59
Tonix Pharmaceuticals Holding (TNXP) United States $0.262B 0.00
Esperion Therapeutics (ESPR) United States $0.212B 0.00
MediWound (MDWD) Israel $0.211B 0.00
OmniAb (OABI) United States $0.209B 0.00
Nanobiotix S.A (NBTX) France $0.208B 0.00
Aldeyra Therapeutics (ALDX) United States $0.201B 0.00
Larimar Therapeutics (LRMR) United States $0.191B 0.00
ProKidney (PROK) United States $0.189B 0.00
Profound Medical (PROF) Canada $0.186B 0.00
4D Molecular Therapeutics (FDMT) United States $0.185B 0.00
Aclaris Therapeutics (ACRS) United States $0.165B 0.00
Innate Pharma SA (IPHYF) France $0.163B 0.00
Journey Medical (DERM) United States $0.162B 0.00
Galectin Therapeutics (GALT) United States $0.153B 0.00
Lyell Immunopharma (LYEL) United States $0.142B 0.00
Lexeo Therapeutics (LXEO) United States $0.140B 0.00
Achieve Life Sciences (ACHV) Canada $0.132B 0.00
Avita Medical (RCEL) United States $0.131B 0.00
VAXART, INC (VXRT) United States $0.128B 0.00
Inhibikase Therapeutics (IKT) United States $0.123B 0.00
Korro Bio (KRRO) United States $0.119B 0.00
Protara Therapeutics (TARA) United States $0.118B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.117B 0.00
Cardiol Therapeutics (CRDL) Canada $0.111B 0.00
Champions Oncology (CSBR) United States $0.108B 17.68
Corbus Pharmaceuticals Holdings (CRBP) United States $0.097B 0.00
Cassava Sciences (SAVA) United States $0.094B 0.00
Unicycive Therapeutics (UNCY) United States $0.088B 0.00
Nutriband (NTRB) United States $0.087B 0.00
Arch Biopartners (ACHFF) Canada $0.086B 0.00
Dominari Holdings (DOMH) United States $0.085B 0.00
Fractyl Health (GUTS) United States $0.083B 0.00
Pyxis Oncology (PYXS) United States $0.079B 0.00
ESSA Pharma (EPIX) Canada $0.077B 0.00
Surrozen (SRZN) United States $0.076B 0.00
Vivani Medical (VANI) United States $0.075B 0.00
Wellgistics Health (WGRX) United States $0.073B 0.00
Inotiv (NOTV) United States $0.067B 0.00
Assertio Holdings (ASRT) United States $0.061B 0.00
PMV Pharmaceuticals (PMVP) United States $0.060B 0.00
Rafael Holdings (RFL) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Metagenomi (MGX) United States $0.058B 0.00
NRx Pharmaceuticals (NRXP) United States $0.056B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.055B 0.00
Avalo Therapeutics (AVTX) United States $0.054B 0.00
Gain Therapeutics (GANX) United States $0.054B 0.00
Telomir Pharmaceuticals (TELO) United States $0.052B 0.00
Context Therapeutics (CNTX) United States $0.052B 0.00
Century Therapeutics (IPSC) United States $0.051B 0.00
Prelude Therapeutics (PRLD) United States $0.049B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.049B 36.67
Klotho Neurosciences (KLTO) United States $0.047B 0.00
Mural Oncology (MURA) Ireland $0.042B 0.00
Karyopharm Therapeutics (KPTI) United States $0.040B 0.00
ElectroCore (ECOR) United States $0.040B 0.00
Iterum Therapeutics (ITRM) Ireland $0.039B 0.00
Acrivon Therapeutics (ACRV) United States $0.039B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.038B 0.00
Jupiter Neurosciences (JUNS) United States $0.037B 0.00
PolyPid (PYPD) Israel $0.036B 0.00
SCYNEXIS (SCYX) United States $0.029B 0.00
China SXT Pharmaceuticals (SXTC) China $0.029B 0.00
Enlivex Therapeutics (ENLV) Israel $0.028B 0.00
Tempest Therapeutics (TPST) United States $0.026B 0.00
FibroGen (FGEN) United States $0.022B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
DURECT (DRRX) United States $0.020B 0.00
BioVie (BIVI) United States $0.020B 0.00
Relmada Therapeutics (RLMD) United States $0.020B 0.00
BioLineRx (BLRX) Israel $0.019B 0.00
Carisma Therapeutics (CARM) United States $0.018B 0.00
Mannatech (MTEX) United States $0.017B 0.00
Vivos Therapeutics (VVOS) United States $0.017B 0.00
Lipocine (LPCN) United States $0.017B 0.00
Lyra Therapeutics (LYRA) United States $0.017B 0.00
CASI Pharmaceuticals (CASI) China $0.017B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.016B 0.00
VYNE Therapeutics (VYNE) United States $0.016B 0.00
Ernexa Therapeutics (ERNA) United States $0.015B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
Citius Pharmaceuticals (CTXR) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.014B 0.00
Cosmos Health (COSM) United States $0.013B 0.00
Minerva Neurosciences (NERV) United States $0.013B 2.20
Scienture Holdings (SCNX) United States $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.011B 0.00
Mangoceuticals (MGRX) United States $0.010B 0.00
Ainos (AIMD) United States $0.010B 0.00
GlycoMimetics (CBIO) United States $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Talphera (TLPH) United States $0.009B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Alaunos Therapeutics (TCRT) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Incannex Healthcare (IXHL) Australia $0.006B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
SHINECO (SISI) China $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Plus Therapeutics (PSTV) United States $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.003B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00